scispace - formally typeset
D

Daniel Rossi Campos

Researcher at Universidade São Francisco

Publications -  7
Citations -  86

Daniel Rossi Campos is an academic researcher from Universidade São Francisco. The author has contributed to research in topics: IVIVC & Bioequivalence. The author has an hindex of 3, co-authored 7 publications receiving 37 citations.

Papers
More filters
Journal ArticleDOI

In vitro – in vivo correlation in the development of oral drug formulation: A screenshot of the last two decades

TL;DR: A large database has been described in this article containing different IVIVC models, with different substances, providing support to scientists interested in this area, as well as to describe the main characteristics of the assessed studies.
Journal ArticleDOI

In Vivo Predictive Dissolution (IPD) for Carbamazepine Formulations: Additional Evidence Regarding a Biopredictive Dissolution Medium.

TL;DR: The results show additional evidence that the medium containing 1% SLS can be classified as a universal biopredictive dissolution tool, and that both of the approaches used to develop the IVIVC provide good in vivo predictability.
Journal ArticleDOI

Sensitive LC-MS/MS method for quantitation of levodopa and carbidopa in plasma: application to a pharmacokinetic study.

TL;DR: A sensitive bioanalytical method by UHPLC-MS/MS was developed and validated for simultaneous levodopa and carbidopa quantification in human plasma using a fast protein precipitation method and demonstrated a sensitive and adequate method for application to pharmacokinetic/bioequivalence studies.
Journal ArticleDOI

In Vitro–In Vivo Correlation for Desvenlafaxine Succinate Monohydrate Extended Release Tablets

TL;DR: An in vitro–in vivo correlation (IVIVC) model for desvenlafaxine succinate monohydrate extended release (ER) tablets was established and the observed low prediction error for C max demonstrated that the IVIVC model was valid for this parameter.